Finding Ways To Reduce Process COGs Upstream And Downstream

In this segment from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration,” our panelists discuss where they see the greatest opportunities for teams to reduce COGs and advise teams to take a holistic approach to cost reduction. For example, don’t waste time and resources pursuing higher titers upstream when clinical need requires relatively small doses. Higher titer may not be a win for cost reduction if it results in greater filter media consumption, which can account for 5-8% of raw material expenditure, according to Mark Fitchmun, founder, president, and CEO of Somatek.